PTC Therapeutics, Inc. Gain (Loss) on Disposition of Assets
PTC Therapeutics, Inc. (PTCT) reported Gain (Loss) on Disposition of Assets of -$544.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-25.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-04-25
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2024-03-31 was -$544.00K.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2023-12-31 was -$671.00K, a 67200.00% decline year-over-year.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2023-09-30 was -$2.00K, a 300.00% decline year-over-year.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was $1.00K.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$806.00K.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2022 was -$80.00K.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2020 was -$16.00K.
- PTC Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2019 was -$312.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$544.00K 10-Q · filed 2024-04-25 | -$1.22M derived: sum of 2 quarters · filed 2024-04-25 | -$1.22M derived: sum of 3 quarters · filed 2024-04-25 | |
| 2023-12-31 | -$671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$673.00K derived: sum of 2 quarters · filed 2024-02-29 | -$806.00K 10-K · filed 2024-02-29 | |
| 2023-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$135.00K 10-Q · filed 2023-10-26 | ||
| 2023-06-30 | -$133.00K 10-Q · filed 2023-08-03 | |||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.00K derived: sum of 3 quarters · filed 2024-02-29 | -$80.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$2.00K derived: sum of 2 quarters · filed 2023-10-26 | -$81.00K 10-Q · filed 2023-10-26 | |
| 2022-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$82.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$79.00K 10-Q · filed 2023-04-27 | |||
| 2020-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $10.00K derived: sum of 2 quarters · filed 2023-02-21 | -$16.00K 10-K · filed 2023-02-21 | |
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$25.00K 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | -$26.00K 10-Q · filed 2021-07-29 | |||
| 2019-12-31 | -$312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$262.00K derived: sum of 2 quarters · filed 2022-02-22 | -$312.00K 10-K · filed 2022-02-22 | |
| 2019-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | -$50.00K 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$2.00K derived: sum of 2 quarters · filed 2021-02-25 | -$2.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$2.00K 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $42.00K derived: sum of 2 quarters · filed 2020-03-02 | -$5.00K 10-K · filed 2020-03-02 | |
| 2017-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$5.00K 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | -$47.00K 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $37.00K 10-K · filed 2018-03-06 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |